%3cb%3e%e4%bb%8e%e9%80%8f%e9%aa%a8%e9%a6%99%e4%b8%ad%e5%88%86%e7%a6%bb%e5%be%97%e5%88%b0%e4%ba%8c%e8%90%9c%e7%b1%bb%e5%8c%96%e5%90%88%e7%89%a9%3c%2fb%3e...
DESCRIPTION
当代细微研究至分子层面TRANSCRIPT
-
200 20153373 Int J Trad Chin Med, March 2015, Vol. 37, No.3
18
1 . [J].
,2011,34(7):437-440,447. 2 ,,,. [J].
,2008,43(7):426-429. 3 . [J]. ,1995,
10(5):38-42. 4 ,,.
()[J]. -,2004,6 (1):25-29.
5 ,. [J].
,2003,25(5):296-298. 6 ,. [J].
,1994,7(1):3-5. 7 ,,,. [J].
,2012,27(8):1998-2003. 8 . [J].
,1995,6(3):48,55-57,80. 9 ,,.
[J]. ,2012,7(5):374-376. 10 .
[J]. ,2002,8(5):10-12. 11 ,.
[J]. ,2003, 9 (11):60-63. 12 ,,.
[J]. ,2008,32(3):293-295. 13 ,,.
[J]. ,1998,18(2):17-24. 14 ,. [J].
,2010,54(22):61-65. 15 ,,,.
[J]. ,2007,42(11):669-671. 16 . [J]. ,1987,
6(3):52-54. 17 .[N].
,2012-05-23(003). 18 ,,,.
[J]. ,2013,54(1):3-7. 2014-09-23
4 4 18- Hydroxyferruginol(6)gaultheronoterpene(7) 12-hydroxydehydroabietic acid(8) TNF-
20 kg-(230 g)/ 8 Fr AHFr D(19 g) Sephadex LH-20 ///TLC1(10.0 mg)3(5.0 mg)Fr F /TLC2(11.0 mg )4(3.0 mg)Fr E /TLC 5(13.0 mg ) 6(12.0 mg) 7(11.5 mg) 8(9.0 mg) 1 3,12-Dihydroxy-13-acetyl-8,11,13-
podocarpatriene[]15D +64(c=0.13)IR (KBr)cm-13 3102 9252 8691 6451 6211 5721 489 C19H26O3 302 2 12,19-Dihydroxy-13-acetyl-8,11,13-podocarpatriene[]15D +46 (c =0.14)IR (KBr)cm-13 3332 9302 8501 6431 5691 489 C19H26O3 302 3 4,12-Dihydroxy-13-acetyl- 19-nor-8,11,13-podocarpatriene[]15D +13(c =0.22 )IR (KBr)cm-13 4732 9362 8501 6361 6081 5671 4891 3151 188887806 C18H24O3 288 4 8,18-Dihydroxy-9(11), 13-abietadien-12-one[]15D -3(c=0.13)IR (KBr) cm-13 4462 9252 8531 7171 6531 384 C20H30O3 318
[Phytochemistry Letters,2014,8:6-9]